SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-20-000359
Filing Date
2020-11-09
Accepted
2020-11-09 14:22:18
Documents
66
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q g082051_10q.htm 10-Q 784128
2 EXHIBIT 31.1 g082051_ex31-1.htm EX-31.1 10430
3 EXHIBIT 32.1 g082051_ex32-1.htm EX-32.1 5789
  Complete submission text file 0001753926-20-000359.txt   5113597

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE sigy-20200930.xml EX-101.INS 1007506
5 XBRL SCHEMA FILE sigy-20200930.xsd EX-101.SCH 46522
6 XBRL CALCULATION FILE sigy-20200930_cal.xml EX-101.CAL 46543
7 XBRL DEFINITION FILE sigy-20200930_def.xml EX-101.DEF 223233
8 XBRL LABEL FILE sigy-20200930_lab.xml EX-101.LAB 350919
9 XBRL PRESENTATION FILE sigy-20200930_pre.xml EX-101.PRE 307273
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 213-457-3772
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

IRS No.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55575 | Film No.: 201297155
SIC: 5944 Retail-Jewelry Stores